Central Drugs Standard Control Organization

Directorate General of Health Services
Ministry of Health & Family Welfare
Government of India

rDNA

S.no Title Release Date Download Pdf Pdf Size
1 Central Inspection Plan Using Risk Based Approach of r- DNA Manufacturing Units for the year- 2024 2024-Jan-31 756 KB
2 List of new drugs (r-DNA origin) approved for manufacture and marketing in India during the period Aug, 2023 to Oct, 2023 2023-Nov-07 397 KB
3 List of New drugs (r-DNA origin) approved for import and marketing in India during the period Sept 2023 to Oct 2023 2023-Nov-07 222 KB
4 List of new drugs (r-DNA origin) approved for manufacture and marketing in India during the period Feb 2023 to 01 Aug 2023 2023-Aug-08 426 KB
5 List of New drugs (r-DNA origin) approved for import and marketing in India during the period Feb 2023 to 01 Aug 2023 2023-Aug-07 317 KB
6 List of new drugs r-DNA origin approved for import and marketing in India for the Year 2020 2023-May-03 231 KB
7 List of new drugs of r-DNA origin approved in CT-20 for import and marketing in India during the period Jul 2021 to Aug 2022 2023-Mar-15 652 KB
8 List of new drugs (r-DNA origin) approved for manufacture and marketing in India in the month JAN 2023 2023-Mar-13 285 KB
9 List of New drugs (r-DNA origin) approved for import and marketing in India in the month JAN 2023 2023-Mar-13 160 KB
10 List of New drugs (r-DNA origin) approved for import and marketing in India during the period Sep, 2022 to Dec, 2022 2023-Feb-14 40 KB
11 List of new drugs (r-DNA origin) approved for manufacture and marketing in India during the period Oct 2022 to Dec 2022 2023-Feb-14 291 KB
12 List of new drugs r-DNA origin approved for manufacture and marketing in India during the period Jul 2021 to Sep 2022 2022-Oct-17 171 KB
13 Form CT-22 & 23 for Year 2021 till 02.07.2021 2021-Jul-01 65 KB
14 Form CT-20 for the year 2021 till 02.07.2021 2021-Jul-01 64 KB
15 List of new drugs (r-DNA origin) approved for manufacture and marketing in India for the Year 2020 2020-Nov-11 72 KB
16 CT permission issued for r-DNA derived drugs for the year 2020 2020-Nov-11 85 KB
17 CT permission issued for r-DNA derived drugs for the year 2019 2020-Nov-10 88 KB
18 Permissions granted in Form 46/46 A 2020-Feb-03 133 KB
19 Permissions granted in Form 45/45 A 2020-Feb-02 311 KB
20 List of rDNA Clinical trials to be Inspected as per the Central Inspection Plan-2019 2019-May-17 85 KB
21 Central Inspection Plan Using Risk Based Approach of r-DNA products Manufacturing Units for 2019 QA-INS-012 2019-May-16 2815 KB